Massimo Gentile

17PUBLICATIONS
127CO-AUTHORS
Predictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 30, 2026
Plasma metabolomics and ctDNA analysis in newly diagnosed diffuse large B-cell lymphoma: an exploratory study.

|Sep 28, 2026
Host Fitness: A Missing Dimension of Precision Medicine in Older Acute Myeloid Leukemia.

|Sep 15, 2026
Mitochondrial Fitness as a Functional Immune Checkpoint in Cancer: Metabolic Plasticity, Tumor Evolution, and Immunotherapy.

|Aug 26, 2026
Bispecific Antibodies for Acute Myeloid Leukemia: From Bone Marrow Immune Niche to Clinical Translation.

|Aug 18, 2026
Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

|Aug 04, 2026
DRP1-mediated mitochondrial fragmentation is a druggable vulnerability in multiple myeloma.

Pageof 3

Frequent Collaborators

11 joint publications

Massimo Gentile

9 joint publications

Fortunato Morabito

7 joint publications

Santino Caserta

7 joint publications

Francesco Mendicino